Cancer Biotech Lands $110M In Financing, Refiles For IPO
Cancer-focused biotechnology group Poseida Therapeutics Inc. said Thursday that it's raising $110 million in its latest financing round, which comes about a week after it refiled plans for a $115 million...To view the full article, register now.
Already a subscriber? Click here to view full article